Skip to content

Clinical trials

Recruiting Leukemia, Myeloid, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Recruiting Clear all

539 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20071
20092
20102
20111
20121
20131
20144
20154
20163
20174
201815
201917
202018
202128
202252
202359
2024115
2025120
202690

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting539

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center31
The First Affiliated Hospital of Soochow University17
City of Hope Medical Center15
National Cancer Institute (NCI)15
Institute of Hematology & Blood Diseases Hospital, China13
Fred Hutchinson Cancer Center11
Memorial Sloan Kettering Cancer Center10
First Affiliated Hospital of Zhejiang University8
Peking University People's Hospital8
Masonic Cancer Center, University of Minnesota7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute539
Myelodysplastic Syndromes140
Precursor Cell Lymphoblastic Leukemia-Lymphoma71
Leukemia46
Recurrence37
Leukemia, Myelomonocytic, Chronic36
Hematologic Neoplasms35
Leukemia, Biphenotypic, Acute32
Myeloproliferative Disorders30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive28

Trials

Showing 76 to 100 of 539. Each trial links to its page on Pharma Observatory.

439 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.